JAPhA Practice Innovations最新文献

{"title":"Impact of a pharmacist-led smoking cessation service on changes in patients’ attitudes toward smoking","authors":"Hayley Wells,&nbsp;Sara McEntee,&nbsp;Yifei Liu","doi":"10.1016/j.japhpi.2025.100028","DOIUrl":"10.1016/j.japhpi.2025.100028","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to examine the impact of a community pharmacist-led smoking cessation service on changes in patients’ attitudes toward smoking, nicotine replacement therapy (NRT) utilization, and rates of tobacco cessation.</div></div><div><h3>Methods</h3><div>Between September 2023 and February 2024, 1 chain community pharmacy located within a health system enrolled people aged 18 years and older who were interested in quitting tobacco cigarettes in a biweekly telephone-based program that provided behavioral support and NRT. Participants completed the Attitude Towards Smoking Scale (ATS-18) before and after the intervention. Paired <em>t</em> tests were conducted to examine changes in patients’ perceptions using the ATS-18. Participants self-reported barriers to NRT before the intervention. Fisher’s exact tests were conducted to examine the relationship between participants who reported previous barriers to NRT use and those who agreed to use NRT. The number of participants who quit smoking was also reported.</div></div><div><h3>Results</h3><div>A total of 71 participants were enrolled in the study, of whom 40 (56.3%) completed the study. Only participants who completed the study were analyzed because those who dropped out did not complete the ATS-18 after the intervention and their changes in attitudes could not be assessed. Participants had a mean age of 59 years, 52% were male, and 59% were African American. Participants reported positive changes in their perceptions of tobacco cessation based on the ATS-18 (<em>P</em> &lt; 0.001). Furthermore, 33 participants agreed to use and pick up NRT and 11 participants self-reported smoking cessation.</div></div><div><h3>Conclusion</h3><div>A pharmacist-led smoking cessation service positively affected patients’ attitudes toward smoking.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100028"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of a pharmacist-led stewardship intervention for antibiotic prescribing in the emergency department","authors":"Emily A. Plauche,&nbsp;Kayla R. Stover,&nbsp;Katie E. Barber,&nbsp;David A. Cretella,&nbsp;Mary Joyce B. Wingler","doi":"10.1016/j.japhpi.2025.100040","DOIUrl":"10.1016/j.japhpi.2025.100040","url":null,"abstract":"<div><h3>Background</h3><div>Antibiotics are commonly prescribed in emergency departments but limited studies have been published describing antimicrobial stewardship interventions in this practice area. The purpose of this study was to assess the effectiveness of a multifaceted pharmacist-led antimicrobial stewardship intervention on selection and duration of antibiotics prescribed in the emergency department.</div></div><div><h3>Methods</h3><div>This single-center, quasi-experimental study evaluated patients discharged from the adult emergency department between October 1, 2021 to February 28, 2022 (preintervention group) and October 1, 2022 to February 28, 2023 (postintervention). Antibiotic default durations were removed from the electronic medical record in September 2022, and education was provided to emergency department prescribers on proper antibiotic selection and duration. Adult patients with a new presumed diagnosis of acute cystitis, acute pyelonephritis, community-acquired pneumonia (CAP), cellulitis, or skin abscess with a new prescription for an oral antibiotic at emergency department discharge were included. The primary outcome was the duration of antibiotic therapy prescribed.</div></div><div><h3>Results</h3><div>There were 220 patients included (110 preintervention; 110 postintervention). Baseline characteristics were similar between groups, and acute cystitis (45%) was the most common indication. The mean antibiotic duration was low in both groups, and there was no statistically significant difference between pre- and postgroups (6.60 vs. 6.35 days; <em>P</em> = 0.382). A 10% decrease in antibiotic inappropriateness was found in the preintervention to postintervention groups (<em>P</em> = 0.075).</div></div><div><h3>Conclusion</h3><div>Overall duration was lower than expected in the pre- and postgroups, with most patients receiving less than 7 days of antibiotics for multiple common infections. Several challenges were identified for performing stewardship in the emergency departments and further interventions have been planned based on the results of this study.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100040"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The evaluation of treatment of chlamydia and gonorrhea in the emergency department at a military treatment facility","authors":"Carlo Tiano,&nbsp;Kayla Scheps,&nbsp;Amber Brammer","doi":"10.1016/j.japhpi.2025.100047","DOIUrl":"10.1016/j.japhpi.2025.100047","url":null,"abstract":"<div><h3>Background</h3><div>Sexually transmitted infections (STIs) have a major impact on global sexual and reproductive health. A systematic review of 13 studies involving emergency department (ED) patients who were tested and empirically treated for <em>Neisseria gonorrhoeae</em> (NG), <em>Chlamydia trachomatis</em> (CT), or both before receiving their nucleic acid amplification test results revealed that up to 84% of patients with positive test results were ultimately undertreated. Addressing this discrepancy is crucial for enhancing the quality of care for patients.</div></div><div><h3>Objective</h3><div>This study aimed to evaluate the impact of pharmacist-led interventions on the incidence of guideline-concordant empirical treatment for chlamydia and gonorrhea in patients presenting to the ED at a large academic military treatment facility (MTF).</div></div><div><h3>Methods</h3><div>A retrospective chart review was conducted at a large academic MTF ED from June 1, 2023, to September 30, 2023. Adult patients screened and treated for CT and NG were included. The primary outcome measured the percentage of patients who received empirical guideline-concordant treatment. Secondary outcomes included the number of patients untreated in the ED, patients who returned for treatment, and those lost to follow-up. After baseline data collection, a pharmacy-led in-service was conducted with educational handouts and education regarding the creation of an STI order set. A postintervention analysis was conducted from February 13, 2024, to April 30, 2024. Data were analyzed with descriptive statistics and chi-squared tests for categorical associations and means and SD for parametric data.</div></div><div><h3>Results</h3><div>In the preintervention group, 108 of 304 screened patients met inclusion criteria; 64 patients (59%) received concordant empirical treatment. After the intervention, 52 of 58 included patients (90%) received guideline-concordant treatment, showing a statistically significant improvement (<em>P</em> &lt; 0.001). Inappropriate treatment duration and dosage were common preintervention issues. After the intervention, adherence to guidelines improved, reducing inappropriate treatment cases.</div></div><div><h3>Conclusion</h3><div>A notable proportion of patients initially received inappropriate treatment. Implementing clinician education and order sets significantly improved compliance with treatment guidelines, demonstrating the effectiveness of targeted quality improvement initiatives.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100047"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of GLP-1 agonists vs. other weight management medications in obese and overweight patients","authors":"Arielle Davidson,&nbsp;Christina Inteso,&nbsp;Nolan Rossman,&nbsp;Toni Larson,&nbsp;Kathryn Dudzinski","doi":"10.1016/j.japhpi.2025.100046","DOIUrl":"10.1016/j.japhpi.2025.100046","url":null,"abstract":"<div><h3>Background</h3><div>Glucagon-like peptide-1 (GLP-1) agonists are efficacious for weight management; however, there are barriers that prevent access. Although studies have shown the efficacy of individual treatments, there is a lack of evidence that compares different classes of weight management medications with each other.</div></div><div><h3>Objective</h3><div>This study aimed to compare the efficacy of GLP-1 agonists with other classes of weight management medications.</div></div><div><h3>Methods</h3><div>This retrospective chart review included patients prescribed a weight management medication by a primary care pharmacist at Corewell Health between June 1, 2022, and June 1, 2023. Patients were assigned to (1) the GLP-1 agonist group or (2) the non-GLP-1 agonist group. The primary outcome was the percentage of patients who reached ≥ 5% weight loss at the end of the treatment course. The secondary outcomes include the percentage of patients who reached ≥ 10% weight loss and ≥ 15% weight loss at the end of the treatment course and average change in body mass index (BMI) at the end of the treatment course.</div></div><div><h3>Results</h3><div>A higher number of patients in the GLP-1 agonist group achieved the primary end point of ≥ 5% weight loss compared with the non-GLP-1 agonist group (29 patients [50.9%] vs. 17 patients [30.9%], <em>P</em> = 0.0318). A logistic model was done, which showed that, when accounting for medication duration, the number of patients in the GLP-1 agonist group who reached the primary end point was not statistically significant compared with the non-GLP-1 agonist group with a <em>P</em> value of 0.0772. There was not a statistically significant difference in the number of patients who achieved ≥ 10% and ≥ 15% weight loss between groups, whereas BMI change was statistically significantly greater in the GLP-1 agonist group.</div></div><div><h3>Conclusion</h3><div>A higher percentage of patients in the GLP-1 agonist group reached ≥ 5% weight loss as compared to patients in the non-GLP-1 agonist group, without regard to medication duration.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100046"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of a Drug Take Back Day event at a large chain community pharmacy","authors":"Kayla Pangilinan,&nbsp;Jessica McDaniel,&nbsp;Pramit Nadpara,&nbsp;Jean-Venable R. Goode","doi":"10.1016/j.japhpi.2025.100042","DOIUrl":"10.1016/j.japhpi.2025.100042","url":null,"abstract":"<div><h3>Background</h3><div>Medication accumulation is a growing public health concern associated with misuse, overdose, pollution, and wasted health care expenditures. Mitigation strategies such as Drug Take Back Day remain underutilized owing to a lack of awareness and access.</div></div><div><h3>Objectives</h3><div>This study aimed to analyze the quantity and characteristics of medications collected, assess donor knowledge and attitudes on safe medication disposal and reasons for medication accumulation, identify patient education opportunities, and compare data collected at 2 drug take back site locations.</div></div><div><h3>Methods</h3><div>Descriptive cross-sectional study conducted at 2 Drug Take Back Day events hosted by a large chain community pharmacy, 1 urban and 1 suburban. Disposed medication characteristics were recorded for the urban site only owing to restrictions from law enforcement, including product name, strength, dosage form, route of administration, category, drug class, length of treatment, condition, and controlled substance schedule. The number of donors and education brochures distributed was tracked, and medications were weighed at conclusion. A 17-question survey was offered to donors 18 years or older to assess demographics, characteristics of disposed medications, and knowledge and attitudes on safe medication disposal. Descriptive statistics were used to analyze results.</div></div><div><h3>Results</h3><div>A total of 311 medications were collected at the urban site. Most were expired noncontrolled prescriptions including supplements and vitamins, analgesics, and cardiovascular drugs. Forty of 246 donors completed the survey. The most identified reasons for excess medication were patient’s death, “excessive quantity,” and medication discontinuation. Eighty percent considered environmental concerns, 48% diversion prevention, and 30% fear of addiction or dependence reasons for participation. Twenty-one donors disposed of 67.8 pounds and 225 donors disposed of 600.9 pounds of medications, with 108 and 250 educational brochures distributed at urban and suburban sites, respectively.</div></div><div><h3>Conclusion</h3><div>Medications collected at Drug Take Back Day were expired noncontrolled prescriptions. Donors valued the environment and poison prevention over diversion and addiction concerns.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100042"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the impact of pharmacist-delivered educational intervention on the willingness to receive HPV vaccine in a dental clinic in New York","authors":"Julian Azzouzi ,&nbsp;Joanne Son ,&nbsp;Katrin Tamari ,&nbsp;Eric Wachs ,&nbsp;Elizabeth J. Unni","doi":"10.1016/j.japhpi.2025.100053","DOIUrl":"10.1016/j.japhpi.2025.100053","url":null,"abstract":"<div><h3>Background</h3><div>Human papillomavirus (HPV) infections are the leading cause of oral and oropharyngeal cancers in the United States, accounting for 70% of new diagnoses. An estimated 90% of newly diagnosed HPV-attributed cancer cases could be preventable with HPV vaccination before exposure, given that the vaccine is 100% effective for at least 12 years. Collaboration between dentists and pharmacists to enhance patient-centered care and vaccine education holds considerable potential to increase HPV vaccine rates among persons aged 9-26 years. Current literature exploring interprofessional collaboration between dentists and pharmacists suggests this partnership may address gaps in patient care, although examples of HPV vaccine initiatives are limited.</div></div><div><h3>Objective</h3><div>This study aimed to assess the impact of screening dental patients’ HPV vaccine status and providing pharmacist-led education and counseling on the intent of patients or guardians to receive the HPV vaccine.</div></div><div><h3>Methods</h3><div>Approved by the institutional review board, a cross-sectional prospective review of patients was conducted at a dental clinic. Patients aged 18-26 years and those aged 9-17 with consenting guardians who had not received the HPV vaccine, verified via the New York State Immunization Information System, were included. Enrolled participants received pharmacist-led education and counseling on HPV and the vaccine, including an educational handout. After the intervention, participants were surveyed to assess their interest in receiving the HPV vaccine. Statistical analysis used a 1-sample proportion test.</div></div><div><h3>Results</h3><div>A total of 67 patients and guardians were approached after prospective review, 32 agreed to participate, 13 were excluded, and a total of 19 were enrolled in the study. After pharmacist intervention, the proportion of participants’ intent to receive the HPV vaccine was 0.895 (<em>P</em> &lt; .001; 95% CI, 0.76–1.00).</div></div><div><h3>Conclusion</h3><div>Screening dental patients’ HPV vaccine status, paired with pharmacist-delivered HPV education and HPV vaccine counseling, may positively affect unvaccinated patients’ or guardians’ intent to receive the HPV vaccine.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100053"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identifying barriers and facilitators to pharmacist-dietitian collaboration to optimize patient health: A focus group study","authors":"Daniel Hough,&nbsp;James Knight,&nbsp;Kimberlee Kilgore Meade,&nbsp;Christopher Pegg,&nbsp;Andrew Beard,&nbsp;Leanne J. Rein,&nbsp;Kenneth C. Hohmeier","doi":"10.1016/j.japhpi.2025.100052","DOIUrl":"10.1016/j.japhpi.2025.100052","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to identify barriers and facilitators to pharmacist-dietitian collaboration by identifying behavioral themes using the COM-B model.</div></div><div><h3>Design</h3><div>This was a qualitative research study using focus groups.</div></div><div><h3>Setting and participants</h3><div>The study was conducted at a single region of a nationwide supermarket pharmacy chain. Focus group participants were pharmacists employed by the pharmacy.</div></div><div><h3>Outcome measures</h3><div>The COM-B model was used to develop questions for the focus group guide. The focus group covered topics such as pharmacists’ knowledge of dietitian services, patient identification and referral processes, medical conditions, workflow integration, time and impact on workflow, pharmacists’ perceived patient reactions, service costs, incentives, general thoughts on referrals, potential benefits and concerns, and demographic information focus group sessions were recorded, transcribed, and analyzed using a rapid analysis technique to categorize text segments using COM-B model domains.</div></div><div><h3>Results</h3><div>A total of 3 focus groups containing 4-5 pharmacists each were completed. Three themes were identified from the rapid analysis: theme 1, knowledgeability of dietary program and motivation to refer; theme 2, barriers and perceptions by pharmacists related to the dietary service; and theme 3, gaps in communication and collaboration.</div></div><div><h3>Conclusion</h3><div>There were several identified barriers and facilitators to improving pharmacist-dietitian collaboration. Future research is needed to explore how best to address these barriers and facilitators to scale collaboration.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100052"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Determining patient motivators to receiving the respiratory syncytial virus vaccine in the community pharmacy setting","authors":"Sarah Stetzer,&nbsp;Cherokee Layson-Wolf,&nbsp;Hyunuk Seung,&nbsp;Eric Kim,&nbsp;Vicki Bulkin,&nbsp;Deanna Tran","doi":"10.1016/j.japhpi.2025.100036","DOIUrl":"10.1016/j.japhpi.2025.100036","url":null,"abstract":"<div><h3>Background</h3><div>A single respiratory syncytial virus (RSV) vaccine dose is indicated for all adults 75 years of age and older and adults 60 to 74 years of age if they are at an increased risk of severe RSV disease. It is important for community pharmacists to understand which marketing methods are the key motivators for patients to receive the RSV vaccine given that they are among the most accessible health care professionals.</div></div><div><h3>Objectives</h3><div>The primary objective is to determine which marketing methods are the main factors that affect patients’ decisions to receive the RSV vaccine. The secondary objective is to determine which marketing methods influence certain demographics of patients.</div></div><div><h3>Methods</h3><div>An anonymous, 8-item survey was administered to individuals and data collection occurred from December 2023 to March 2024. The survey collected information about participants’ comorbidities, how participants heard about the RSV vaccine, what marketing tactics were most influential in their decision to receive the RSV vaccine, and other nonmarketing factors that may have motivated participants.</div></div><div><h3>Results</h3><div>Forty-eight surveys were collected and analyzed. More than half of the participants did not report any comorbid conditions (52.1%). The most frequently reported comorbid conditions were diabetes (25%) and chronic lung disease (18.8%). Television, commercials or news (62.5%), and primary care providers (54.2%) were selected as the 2 most frequently reported ways participants had heard about the RSV vaccine. Of all the available marketing methods provided, participants chose primary care providers (41.7%) as having the most influence on their decision to get the RSV vaccine.</div></div><div><h3>Conclusion</h3><div>These findings give insight into which marketing methods are more likely to influence patients to receive the RSV vaccine. Primary care providers were found to be the primary motivators for participants to receive the RSV vaccine. This study reinforces the importance of community pharmacists’ partnerships with providers to help increase access to information and receipt of RSV vaccination.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100036"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expanding horizons: Resident research makes its debut in JAPhA Practice Innovations","authors":"Darin C. Ramsey PharmD, BCPS, BCACP","doi":"10.1016/j.japhpi.2025.100054","DOIUrl":"10.1016/j.japhpi.2025.100054","url":null,"abstract":"","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100054"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacist confidence, comfort, and experience screening for and addressing social risks","authors":"Martha Schanandore,&nbsp;Courtney E. Gamston,&nbsp;Lindsey Hohmann,&nbsp;Lena McDowell,&nbsp;Greg Peden,&nbsp;Kimberly Braxton Lloyd","doi":"10.1016/j.japhpi.2025.100033","DOIUrl":"10.1016/j.japhpi.2025.100033","url":null,"abstract":"<div><h3>Background</h3><div>Social determinants of health (SDoH) account for 50%-60% of health outcomes. Pharmacists are uniquely positioned to screen for adverse SDoH (social risks), and address social needs, conditions an individual seeks assistance with immediately. However, previous research has demonstrated that pharmacists lack confidence and experience performing this screening.</div></div><div><h3>Objective</h3><div>This study aimed to assess pharmacist self-perceived knowledge, comfort, and experience screening for SDoH and confidence addressing social needs.</div></div><div><h3>Methods</h3><div>Registered Alabama pharmacists were invited via e-mail to complete an incentivized, anonymous survey. Outcomes were measured via multiple-choice and Likert-type scales, including (1) confidence and comfort with screening and making referrals, (2) current screening and referral activities, (3) awareness of resources, (4) willingness to implement SDoH services, and (5) attitudes regarding SDoH services and were analyzed using descriptive statistics, chi-square analyses, and Pearson correlations.</div></div><div><h3>Results</h3><div>The mean age of the 310 survey participants was 45 ± 9.8 years, and 72% identified as female. Notably, 65% reported working in the community setting; 62% and 65%, respectively, reported a lack of knowledge and ability to identify risks; 84% reported lacking confidence in their ability to address social needs; 55% reported not feeling equipped to use available resources; and 30% indicated currently screening for SDoH at their practice site. Pharmacists identified lack of time (72%) as the most common barrier to screening. Respondents identified lack of resources (65%), personnel (49%), and confidence (32%) and uncertainty of how to link patients to available resources (34%) as other barriers. Most respondents (56%) felt pharmacists could make a positive impact on social risks.</div></div><div><h3>Conclusion</h3><div>Pharmacists reported lack of knowledge, comfort, and experience screening for social risks and barriers to screening for and addressing identified needs. Responses suggest a need for additional training and evaluation of strategies to decrease barriers to SDoH screening and management.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 2","pages":"Article 100033"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143705903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}